FAM83A was found to be highly expressed in lung cancer, breast cancer, and pancreatic cancer [60–62].Its high expression was negatively correlated with methylation levels and predicted poor prognosis in LUAD patients [60]. Here, SACK1A is linked to lung carcinoma.